Design Therapeutics
DSGN
DSGN
95 hedge funds and large institutions have $206M invested in Design Therapeutics in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 100 → 95 (-5)
17% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 18
Holders
95
Holding in Top 10
2
Calls
$28K
Puts
$16K
Top Buyers
| 1 | +$4.79M | |
| 2 | +$3.45M | |
| 3 | +$2.36M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$2.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.58M |
Top Sellers
| 1 | -$1.85M | |
| 2 | -$1.79M | |
| 3 | -$1.62M | |
| 4 |
Millennium Management
New York
|
-$1.12M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$661K |